Can Neutrophil Gelatinase–associated Lipocalin Help Depict Early Contrast Material–induced Nephropathy?

Early detection and intervention using neutrophil gelatinase-associated lipocalin (NGAL) may improve renal outcome of acute contrast media induced nephropathy: A randomized controlled trial in patients undergoing intra-arterial angiography (ANTI-CIN Study)

(2011) Gernot Schilcher et al.   BMC Nephrology

Choice of Contrast Medium in Patients With Impaired Renal Function Undergoing Percutaneous Coronary Intervention

(2009) Rainer Wessely et al.   Circulation-Cardiovascular Interventions

Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Progression of Chronic Kidney Disease

(2009) D. Bolignano et al.   Clinical Journal of the American Society of Nephrology

Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery—A prospective cohort study*

(2009) Anja Haase-Fielitz et al.   CRITICAL CARE MEDICINE

Renal Safety of Gadolinium-based Contrast Media in Patients with Chronic Renal Insufficiency

(2009) Elena Ledneva et al.   RADIOLOGY

A Comparison of Contemporary Definitions of Contrast Nephropathy in Patients Undergoing Percutaneous Coronary Intervention and a Proposal for a Novel Nephropathy Grading System

(2008) Kishore J. Harjai et al.   AMERICAN JOURNAL OF CARDIOLOGY

Neutrophil Gelatinase–Associated Lipocalin (NGAL) as a Marker of Kidney Damage

(2008) Davide Bolignano et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Prevention of Contrast-Induced Nephropathy with Volume Expansion

(2007) S. D. Weisbord et al.   Clinical Journal of the American Society of Nephrology